Reports, Forms, and Record Keeping Requirements, 42225-42226 [2017-18827]

Download as PDF asabaliauskas on DSKBBXCHB2PROD with NOTICES Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices John T. Murchison, Jr. (TN) Axel J.M. Murphy (MN) Charles M. Naylis (PA) Craig J. Nelson (IL) Richard A. Nigro (NJ) Thomas S. O’Brien (TX) Paul T. Ozbun (OK) Modesto F. Pedote (NY) David M. Pomeroy (IA) Matthew C. Preston (KY) Anthony A. Rachuy (MN) Dwight B. Richardson (OK) James C. Rocco (NJ) Patrick J. Severance (NY) Billy L. Wagner (IL) Steven L. Wear (ND) James T. Young (MI) David J. Zelhart (IL) The drivers were included in docket number FMCSA–2015–0061. Their exemptions are applicable as of July 23, 2017, and will expire on July 23, 2019. As of July 26, 2017, and in accordance with 49 U.S.C. 31136(e) and 31315, the following ten individuals have satisfied the renewal conditions for obtaining an exemption from the rule prohibiting drivers with ITDM from driving CMVs in interstate commerce (76 FR 32012; 76 FR 44650): Teddy L. Beach (ND) Franklin L. Bell (NE) Jeffrey F. Borelli (OH) Dale E. Burke (WA) Boyd L. Croshaw (UT) Derek Haagensen (MN) Todd J. Smith (NY) Andrew C. Winsberg (WA) Nathan E. Woodin (IL) Vicky A. Yernesek (WI) The drivers were included in docket number FMCSA–2011–0143. Their exemptions are applicable as of July 26, 2017, and will expire on July 26, 2019. As of July 28, 2017, and in accordance with 49 U.S.C. 31136(e) and 31315, the following 34 individuals have satisfied the renewal conditions for obtaining an exemption from the rule prohibiting drivers with ITDM from driving CMVs in interstate commerce (73 FR 33144; 73 FR 43817; 74 FR 26467; 74 FR 37293): Jeromy B. Birchard (MN) Bradley M. Brown (TX) Robert F. Browne III (NH) William M. Camp (GA) Robert F. Carter (IN) Scott A. Cary (NC) Eugene W. Clark, Jr. (WI) William D. Cornwell III (OH) Adam F. Demeter (NY) Brian P. Dionne (NH) Richard C. Dunn (CT) Donald K. Ennis (NC) Larry A. Fritz (PA) Jerret L. Gerber (WI) Alan L. Johnson (WA) Richard B. Lorimer (MO) VerDate Sep<11>2014 17:37 Sep 05, 2017 Jkt 241001 Lester J. Manis (MD) Troy A. Martinson (WI) Richard L. Miller (OH) Jerome A. Mjolsness (MN) Richard Murphy (NH) Edward F. Murray (NY) Nicholas W. Pomnitz (NJ) Clayton M. Reynolds (WA) Brandon M. Ross (ND) Jeffrey S. SaintVincent (CA) Patrick D. Schiller (MI) Bruce D. Schmoyer (PA) Joseph E. Sobiech (WI) James L. Swedenburg (MN) Gary A. Sweeney (NY) Lawrence M. Tanner (NV) Robert D. Tarkington (AK) Joshua C. Webb (AR) The drivers were included in one of the following docket numbers: FMCSA– 2008–0137; FMCSA–2009–0122. Their exemptions are applicable as of July 28, 2017, and will expire on July 28, 2019. In accordance with 49 U.S.C. 31315, each exemption will be valid for two years from the effective date unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained prior to being granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136 and 31315. Issued on: August 25, 2017. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2017–18826 Filed 9–5–17; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION National Highway Traffic Safety Administration [U.S. DOT Docket No. NHTSA–2017–0057] Reports, Forms, and Record Keeping Requirements National Highway Traffic Safety Administration, DOT. ACTION: Notice. AGENCY: In compliance with the Paperwork Reduction Act of 1995, this notice announces that the Information Collection Request (ICR) abstracted below will be submitted to the Office of Management and Budget (OMB) for review. The ICR describes the nature of the information collection and its expected burden. DATES: Comments must be received on or before November 6, 2017. SUMMARY: PO 00000 Frm 00170 Fmt 4703 Sfmt 4703 42225 You may submit comments identified by DOT Docket ID Number NHTSA–2017–0057 using any of the following methods: Electronic submissions: Go to http:// www.regulations.gov and follow the online instructions for submitting comments. Mail, Hand Delivery, or Courier: U.S. Department of Transportation, 1200 New Jersey Avenue SE., Docket Management Facility, M–30, Room W12–140, Washington, DC 20590. Docket hours are 9 a.m. to 5 p.m., Monday through Friday, except Federal holidays; phone 202–647–5527. FOR FURTHER INFORMATION CONTACT: Ms. Amy Berning, Contracting Officer’s Representative, Office of Behavioral Safety Research, National Highway Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington, DC 20590. Ms. Berning’s phone number is 202–366–5587 and the email address is amy.berning@dot.gov. SUPPLEMENTARY INFORMATION: OMB Control Number: None. Title: Drug Use by Drivers Arrested for Driving Under the Influence or Driving While Under the Influence of Drugs Form Number: This collection of information uses no standard forms. Type of Request: Regular. Respondents—Under this proposed effort, NHTSA will collect data from approximately 1,000 drivers/ participants. Estimated time per Participant— NHTSA estimates that participants will spend an average of 15 minutes to complete the survey and provide the oral fluid specimen. The respondents would not incur any reporting cost or record keeping burden from the data collection. Total Estimated Annual Burden Hours: 250 hours per year. Frequency of Collection: Each participant will provide one oral fluid sample and respond to the survey questions only once during the study period. Summary of Collection of Information: This study will estimate the prevalence of drugs in drivers arrested for impaired driving. The goal is to better understand the frequency of alcohol, prescription, over-the-counter, and illicit drugs, in impaired driving arrests. A minimum of 1,000 drivers arrested for impaired driving, who consent to voluntarily participate, will provide an oral fluid sample and respond to interview questions. The oral fluid sample provides information on the participant’s use of 50 or more drug(s). Trained researchers will ask ADDRESSES: E:\FR\FM\06SEN1.SGM 06SEN1 asabaliauskas on DSKBBXCHB2PROD with NOTICES 42226 Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices participants questions regarding demographics, driving, alcohol, and drug use. Data collection would take place over a six month period at two to three sites across the country. The research team will coordinate with the local police departments and officials at these sites. There will be a private room at each police department’s booking facility for this study’s use. A police officer will briefly inform the driver/potential participant of the opportunity to participate in a research study sponsored by NHTSA. If the driver is interested, a researcher will provide full information about the study. If the driver is not interested, no information will be collected on that person. The researcher will highlight that participation is voluntary, the oral fluid and survey responses will be anonymous, and the participant may stop the study at any time. The results of the drug test and questionnaire will not be provided to anyone outside of the research team (including to the participant), and participation in the study will not be used to help or hurt the individual in any related legal proceedings. All participants must be 18 years of age or older to participate. To provide an oral fluid sample, a participant simply places a cotton swab in their mouth for approximately 5 minutes. The specimen will be sent to an independent laboratory for analyses. The participant will also be provided a self-report survey on alcohol and drug use, perceptions of impaired driving, and driving behaviors. This survey will take approximately 10 minutes and will be conducted via an electronic tablet or, if needed, a paper copy will be available. All data will be housed on a secure data collection and management site. No identifying participant information will be collected or used in the study. Drug test results will only be associated with survey responses using a project subject code. Description of the Need for the Information and Proposed Use of the Information: The purpose of this study is to examine the drug presence and drug use characteristics of drivers arrested for impaired driving. While there is extensive research on alcoholimpaired driving, significantly less is known about the prevalence and risk factors of over-the-counter, prescription, and illegal drug-positive driving. A significant reason for this lack of information is that impaired drivers with alcohol in their system are rarely tested for other drugs and, when tested, are only tested for a few drugs. To address this knowledge gap, this study will obtain a biological specimen from VerDate Sep<11>2014 17:37 Sep 05, 2017 Jkt 241001 the drivers, to directly learn about drug use, along with collecting self-report data. The data will be used to better understand the prevalence of a variety of drugs in impaired drivers and better understand risk factors for drugimpaired driving. Authority: 44 U.S.C. Section 3506(c)(2)(A). Issued in Washington, DC. Jeff Michael, Associate Administrator, Research and Program Development. [FR Doc. 2017–18827 Filed 9–5–17; 8:45 am] BILLING CODE 4910–59–P DEPARTMENT OF THE TREASURY Internal Revenue Service Proposed Collection; Comment Request for Sale of Residence From Qualified Personal Residence Trust (T.D. 8743) Internal Revenue Service (IRS), Treasury. ACTION: The Internal Revenue Service (IRS), as part of its continuing effort to reduce paperwork and respondent burden, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. The IRS is soliciting comments concerning information collection requirements related to Sale of Residence From Qualified Personal Residence Trust. AGENCY: Written comments should be received on or before November 6, 2017 to be assured of consideration. ADDRESSES: Direct all written comments to L. Brimmer, Internal Revenue Service, Room 6526, 1111 Constitution Avenue NW., Washington, DC 20224. Requests for additional information or copies of the regulation should be directed to Taquesha Cain, Room 6526, 1111 Constitution Avenue NW., Washington, DC 20224, or through the internet at Taquesha.R.Cain@irs.gov. SUPPLEMENTARY INFORMATION: Title: Sale of Residence From Qualified Personal Residence Trust. OMB Number: 1545–1485. Regulation Project Number: T.D. 8743 Abstract: Internal Revenue Code section 2702(a)(3) provides special favorable valuation rules for valuing the gift of a personal residence trust. Regulation section 25.2702–5(a)(2) provides that if the trust fails to comply with the requirements contained in the regulations, the trust will be treated as DATES: PO 00000 Frm 00171 Fmt 4703 Sfmt 9990 complying if a statement is attached to the gift tax return reporting the gift stating that a proceeding has been commenced to reform the instrument to comply with the requirements of the regulations. Current Actions: There is no change in the paperwork burden previously approved by OMB. Type of Review: Extension of a currently approved collection. Affected Public: Individuals or households. Estimated Number of Respondents: 200. Estimated Time per Respondent: 3 hour, 7 minutes. Estimated Total Annual Burden Hours: 625. The following paragraph applies to all of the collections of information covered by this notice: An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless the collection of information displays a valid OMB control number. Books or records relating to a collection of information must be retained as long as their contents may become material in the administration of any internal revenue law. Generally, tax returns and tax return information are confidential, as required by 26 U.S.C. 6103. Request for comments: Comments submitted in response to this notice will be summarized and/or included in the request for OMB approval. All comments will become a matter of public record. Comments are invited on: (a) Whether the collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Approved: August 29, 2017. L. Brimmer, Senior Tax Analyst. [FR Doc. 2017–18839 Filed 9–5–17; 8:45 am] BILLING CODE 4830–01–P E:\FR\FM\06SEN1.SGM 06SEN1

Agencies

[Federal Register Volume 82, Number 171 (Wednesday, September 6, 2017)]
[Notices]
[Pages 42225-42226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18827]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[U.S. DOT Docket No. NHTSA-2017-0057]


Reports, Forms, and Record Keeping Requirements

AGENCY: National Highway Traffic Safety Administration, DOT.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, this 
notice announces that the Information Collection Request (ICR) 
abstracted below will be submitted to the Office of Management and 
Budget (OMB) for review. The ICR describes the nature of the 
information collection and its expected burden.

DATES: Comments must be received on or before November 6, 2017.

ADDRESSES: You may submit comments identified by DOT Docket ID Number 
NHTSA-2017-0057 using any of the following methods:
    Electronic submissions: Go to http://www.regulations.gov and follow 
the on-line instructions for submitting comments.
    Mail, Hand Delivery, or Courier: U.S. Department of Transportation, 
1200 New Jersey Avenue SE., Docket Management Facility, M-30, Room W12-
140, Washington, DC 20590.
    Docket hours are 9 a.m. to 5 p.m., Monday through Friday, except 
Federal holidays; phone 202-647-5527.

FOR FURTHER INFORMATION CONTACT: Ms. Amy Berning, Contracting Officer's 
Representative, Office of Behavioral Safety Research, National Highway 
Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington, 
DC 20590. Ms. Berning's phone number is 202-366-5587 and the email 
address is amy.berning@dot.gov.

SUPPLEMENTARY INFORMATION: 
    OMB Control Number: None.
    Title: Drug Use by Drivers Arrested for Driving Under the Influence 
or Driving While Under the Influence of Drugs
    Form Number: This collection of information uses no standard forms.
    Type of Request: Regular.
    Respondents--Under this proposed effort, NHTSA will collect data 
from approximately 1,000 drivers/participants.
    Estimated time per Participant--NHTSA estimates that participants 
will spend an average of 15 minutes to complete the survey and provide 
the oral fluid specimen. The respondents would not incur any reporting 
cost or record keeping burden from the data collection.
    Total Estimated Annual Burden Hours: 250 hours per year.
    Frequency of Collection: Each participant will provide one oral 
fluid sample and respond to the survey questions only once during the 
study period.
    Summary of Collection of Information: This study will estimate the 
prevalence of drugs in drivers arrested for impaired driving. The goal 
is to better understand the frequency of alcohol, prescription, over-
the-counter, and illicit drugs, in impaired driving arrests.
    A minimum of 1,000 drivers arrested for impaired driving, who 
consent to voluntarily participate, will provide an oral fluid sample 
and respond to interview questions. The oral fluid sample provides 
information on the participant's use of 50 or more drug(s). Trained 
researchers will ask

[[Page 42226]]

participants questions regarding demographics, driving, alcohol, and 
drug use.
    Data collection would take place over a six month period at two to 
three sites across the country. The research team will coordinate with 
the local police departments and officials at these sites. There will 
be a private room at each police department's booking facility for this 
study's use.
    A police officer will briefly inform the driver/potential 
participant of the opportunity to participate in a research study 
sponsored by NHTSA. If the driver is interested, a researcher will 
provide full information about the study. If the driver is not 
interested, no information will be collected on that person. The 
researcher will highlight that participation is voluntary, the oral 
fluid and survey responses will be anonymous, and the participant may 
stop the study at any time. The results of the drug test and 
questionnaire will not be provided to anyone outside of the research 
team (including to the participant), and participation in the study 
will not be used to help or hurt the individual in any related legal 
proceedings. All participants must be 18 years of age or older to 
participate.
    To provide an oral fluid sample, a participant simply places a 
cotton swab in their mouth for approximately 5 minutes. The specimen 
will be sent to an independent laboratory for analyses. The participant 
will also be provided a self-report survey on alcohol and drug use, 
perceptions of impaired driving, and driving behaviors. This survey 
will take approximately 10 minutes and will be conducted via an 
electronic tablet or, if needed, a paper copy will be available. All 
data will be housed on a secure data collection and management site. No 
identifying participant information will be collected or used in the 
study. Drug test results will only be associated with survey responses 
using a project subject code.
    Description of the Need for the Information and Proposed Use of the 
Information: The purpose of this study is to examine the drug presence 
and drug use characteristics of drivers arrested for impaired driving. 
While there is extensive research on alcohol-impaired driving, 
significantly less is known about the prevalence and risk factors of 
over-the-counter, prescription, and illegal drug-positive driving. A 
significant reason for this lack of information is that impaired 
drivers with alcohol in their system are rarely tested for other drugs 
and, when tested, are only tested for a few drugs. To address this 
knowledge gap, this study will obtain a biological specimen from the 
drivers, to directly learn about drug use, along with collecting self-
report data.
    The data will be used to better understand the prevalence of a 
variety of drugs in impaired drivers and better understand risk factors 
for drug-impaired driving.

    Authority: 44 U.S.C. Section 3506(c)(2)(A).

    Issued in Washington, DC.
Jeff Michael,
Associate Administrator, Research and Program Development.
[FR Doc. 2017-18827 Filed 9-5-17; 8:45 am]
 BILLING CODE 4910-59-P